Women Starting Early Menopausal Hormone Therapy Have Lower Risk for Osteoporosis, Fracture .
Early initiation of menopausal hormone therapy (MHT) may reduce the risk of osteoporosis-related fractures in women, according to recent clinical findings. Women who began hormone therapy closer to the onset of menopause demonstrated lower fracture risk compared with those who initiated treatment later or did not receive therapy. Estrogen plays a key role in maintaining bone density by regulating bone remodeling and reducing bone resorption, and declining estrogen levels after menopause are strongly associated with accelerated bone loss. These results suggest that timely initiation of hormone therapy may help preserve bone strength and reduce fracture risk in appropriately selected patients. The findings highlight the importance of individualized risk assessment when considering strategies to prevent osteoporosis-related fractures.
Read the full News article from Healio
Read Article
DISCLAIMER
This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.
